A Real-World Analysis Evaluating Characteristics And Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin Using A Large Health Plan Database (Optum Research Database: 6 Month Follow Up Study).

Trial Profile

A Real-World Analysis Evaluating Characteristics And Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin Using A Large Health Plan Database (Optum Research Database: 6 Month Follow Up Study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2016

At a glance

  • Drugs Canagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 May 2016 New trial record
    • 16 May 2016 Results published in the Media Release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top